MX2020003134A - Preparaciones solidas que contienen extractos de pelargonium sidoides y un compuesto de acido silicico, y metodo para preparar las mismas. - Google Patents
Preparaciones solidas que contienen extractos de pelargonium sidoides y un compuesto de acido silicico, y metodo para preparar las mismas.Info
- Publication number
- MX2020003134A MX2020003134A MX2020003134A MX2020003134A MX2020003134A MX 2020003134 A MX2020003134 A MX 2020003134A MX 2020003134 A MX2020003134 A MX 2020003134A MX 2020003134 A MX2020003134 A MX 2020003134A MX 2020003134 A MX2020003134 A MX 2020003134A
- Authority
- MX
- Mexico
- Prior art keywords
- acid compound
- silicic acid
- preparation
- pelargonium sidoides
- solid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se relaciona con una preparación sólida que incluye un extracto de Pelargonium sidoides y un compuesto de ácido silícico, que se puede formular en una forma sólida mediante adsorción directa del extracto de Pelargonium sidoides sobre un compuesto de ácido silícico, y un método de preparación de la misma. Debido a que la preparación sólida que incluye el extracto de Pelargonium sidoides y el compuesto de ácido silícico de la presente invención tiene mayor estabilidad que una preparación líquida como un jarabe, y no tiene aditivos tales como azúcares, no existe preocupación acerca de una contaminación microbiana o descomposición de la preparación. Además, es posible envasar la preparación sólida individualmente. Debido a que la preparación sólida es menor en volumen que la preparación líquida, es bastante manejable, y también existe una conveniencia de que no son necesarias herramientas adicionales para injerir el fármaco. Además, el ingrediente activo se puede injerir en la cantidad igual cada vez.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20130159980A KR101497508B1 (ko) | 2013-12-20 | 2013-12-20 | 펠라고니움 시도이데스 추출물 및 규산 화합물을 포함하는 고형 제제 및 이의 제조 방법 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2020003134A true MX2020003134A (es) | 2020-07-28 |
Family
ID=53025925
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015016942A MX2015016942A (es) | 2013-12-20 | 2014-12-19 | Preparaciones solidas que contienen extractos de pelargonium sidoides y un compuesto de acido silicico, y metodo para preparar las mismas. |
MX2020003134A MX2020003134A (es) | 2013-12-20 | 2015-12-09 | Preparaciones solidas que contienen extractos de pelargonium sidoides y un compuesto de acido silicico, y metodo para preparar las mismas. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015016942A MX2015016942A (es) | 2013-12-20 | 2014-12-19 | Preparaciones solidas que contienen extractos de pelargonium sidoides y un compuesto de acido silicico, y metodo para preparar las mismas. |
Country Status (10)
Country | Link |
---|---|
US (1) | US20160287651A1 (es) |
EP (1) | EP3082774A4 (es) |
KR (1) | KR101497508B1 (es) |
CN (1) | CN105246465B (es) |
BR (1) | BR112015030090B1 (es) |
HK (1) | HK1215669A1 (es) |
MX (2) | MX2015016942A (es) |
PH (1) | PH12015502499A1 (es) |
RU (1) | RU2612085C1 (es) |
WO (1) | WO2015093899A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT201800002457A1 (it) * | 2018-02-07 | 2019-08-07 | Neilos S R L | Composizione per la prevenzione e il trattamento delle affezioni delle vie respiratorie |
KR20200004178A (ko) | 2018-07-03 | 2020-01-13 | 한국유나이티드제약 주식회사 | 펠라고니움 시도이데스 추출물을 포함하는 약학 조성물 및 이의 제조방법 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9501127D0 (en) * | 1995-01-20 | 1995-03-08 | Wellcome Found | Tablet |
KR100210106B1 (ko) * | 1997-06-02 | 1999-07-15 | 윤종용 | 냉장고의 급수호스 고정장치 |
DE102004032439A1 (de) * | 2004-07-05 | 2006-02-02 | Iso Arzneimittel Gmbh & Co Kg | Verwendung von Extrakten aus Wurzeln von Pelargonium sidoides und Pelargonium reniforme |
EP1990062A1 (en) * | 2006-02-20 | 2008-11-12 | ASAHI BREWERIES, Ltd. | Granules, tablets and method of producing the same |
DE102006032326A1 (de) * | 2006-07-12 | 2008-01-17 | Dr. Willmar Schwabe Gmbh & Co. Kg | Verwendung von Extrakten aus Pelargonium sidoides und/oder Pelargonium reniforme sowie diese Extrakte enthaltende Mittel und pharmazeutische Formulierungen |
AU2008238323B2 (en) * | 2007-04-17 | 2013-01-31 | Dr. Willmar Schwabe Gmbh & Co. Kg | Dry extracts of Pelargonium sidoides and Pelargonium reniforme |
KR20100033378A (ko) * | 2007-06-22 | 2010-03-29 | 브리스톨-마이어스 스큅 컴퍼니 | 아타자나비르를 함유하는 정제 조성물 |
CN103041768A (zh) * | 2013-01-09 | 2013-04-17 | 内蒙古科技大学 | 一种改性硅酸钙吸附剂的制备方法 |
-
2013
- 2013-12-20 KR KR20130159980A patent/KR101497508B1/ko active IP Right Grant
-
2014
- 2014-12-19 BR BR112015030090-1A patent/BR112015030090B1/pt active IP Right Grant
- 2014-12-19 EP EP14872706.8A patent/EP3082774A4/en not_active Withdrawn
- 2014-12-19 WO PCT/KR2014/012592 patent/WO2015093899A1/en active Application Filing
- 2014-12-19 US US14/889,619 patent/US20160287651A1/en not_active Abandoned
- 2014-12-19 MX MX2015016942A patent/MX2015016942A/es active IP Right Grant
- 2014-12-19 CN CN201480029852.1A patent/CN105246465B/zh active Active
- 2014-12-19 RU RU2015148756A patent/RU2612085C1/ru active
-
2015
- 2015-10-29 PH PH12015502499A patent/PH12015502499A1/en unknown
- 2015-12-09 MX MX2020003134A patent/MX2020003134A/es unknown
-
2016
- 2016-03-29 HK HK16103591.9A patent/HK1215669A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
EP3082774A1 (en) | 2016-10-26 |
WO2015093899A1 (en) | 2015-06-25 |
RU2612085C1 (ru) | 2017-03-02 |
EP3082774A4 (en) | 2017-05-10 |
BR112015030090A2 (pt) | 2017-07-25 |
BR112015030090B1 (pt) | 2023-02-14 |
CN105246465A (zh) | 2016-01-13 |
HK1215669A1 (zh) | 2016-09-09 |
US20160287651A1 (en) | 2016-10-06 |
PH12015502499B1 (en) | 2016-02-22 |
MX2015016942A (es) | 2016-04-25 |
KR101497508B1 (ko) | 2015-03-03 |
PH12015502499A1 (en) | 2016-02-22 |
CN105246465B (zh) | 2018-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2017279565B2 (en) | RNA formulation for immunotherapy | |
PH12014502778B1 (en) | Antibody formulation | |
MX338515B (es) | Derivados de tetrahidroquinolina utiles como inhibidores de bromodominio. | |
AU2012265219A8 (en) | Compounds containing hydrido-tricyano-borate anions | |
BR112015000229A2 (pt) | formulações aquosas estáveis de etanercept | |
WO2013057013A3 (en) | Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors | |
MX360700B (es) | Formulacion concentrada liquida que contiene un insecticida de piripiropeno ii. | |
MX360698B (es) | Formulación concentrada líquida que contiene un insecticida de piripiropeno i. | |
MX2021009377A (es) | Formulaciones de espuma y aparatos para su suministro. | |
MX362770B (es) | Formulación concentrada líquida que contiene un insecticida de piripiropeno iii. | |
WO2014121764A3 (en) | 2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purine derivatives, use thereof as medicaments, and pharmaceutical compositions | |
MX364610B (es) | Derivados de 1- [m-carboxamido (hetero) aril-metil]-heterociclil-c arboxamida. | |
NZ702342A (en) | Pharmaceutical formulation | |
PH12016502544B1 (en) | Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor | |
WO2012173458A3 (ko) | 식물 세포 내에 안정화된 활성 물질 및 그 제조방법 | |
MX2020003134A (es) | Preparaciones solidas que contienen extractos de pelargonium sidoides y un compuesto de acido silicico, y metodo para preparar las mismas. | |
WO2015038736A3 (en) | Formulations for cgrp receptor antagonists | |
MX2014014579A (es) | Composiciones farmaceuticas topicas de tipo emulsion aceite en agua que contienen un retinoide. | |
EA032913B1 (ru) | Препараты производных пиримидиндиона | |
MX359955B (es) | Formulación de aroma y fragancia (iii). | |
MY170724A (en) | Use of certain trioxygenated benzene derivatives in body fat management | |
WO2011093831A3 (en) | Effervescent formulations comprising cefprozil as active agent | |
WO2012007758A3 (en) | Pharmaceutical formulations | |
MX2015004310A (es) | Formulacion de aroma y fragancia (v). | |
MX360017B (es) | Formulación de aroma y fragancia (iv). |